Medical Research
(H80)
990 on File
ADENOID CYSTIC CARCINOMA ORGANIZATION INTERNATIONAL
Financial strength (30%)
68/100
Reliability (20%)
55/100
Effectiveness (25%)
31/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$64K
Total Revenue
$8K
Total Expenses
$370K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
50.8%
Fundraising Efficiency
N/A
Operating Reserve
566.49x
Liability-to-Asset
0.0%
Revenue Diversification
88.1%
Compared with Peers
FY 2023
Compared with 1,152 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
50.8% | 80.3% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
566.5 mo | 37.0 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
88.1% | 100.0% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
80.5% | -1.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-51.8% | -3.6% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
87.8% | 12.7% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $64K | $8K | $370K | 50.8% | — |
| 2022 | $36K | $16K | $310K | 58.2% | — |
| 2021 | $92K | $10K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.